| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4237824 | Journal of Vascular and Interventional Radiology | 2014 | 11 Pages |
Abstract
The findings in this study suggest that approximately 50% of administered 90Y dose is taken up by targeted infiltrative HCC with PVT. Intratumoral 90Y dose ⥠100 Gy in unresectable infiltrative HCC via a lobar intraarterial approach is a positive prognostic factor for survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Nima MD, James R. PhD, Minzhi MD, Juan C. MD, Bruce J. MD, David M. MD, Hyun S. MD,